Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Shares Outstanding (Entity) (2009 - 2026)

Updated

Regeneron Pharmaceuticals' Shares Outstanding (Entity) came in at 102.8 million for Q2 2026, down 2.2% from 105.1 million a year earlier and down 1.2% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Shares Outstanding (Entity) (2009 - 2026) Analysis & Trends

For FY2025, Regeneron Pharmaceuticals' Shares Outstanding (Entity) was 104.6 million, down 3.1% from FY2024.

  • Shares Outstanding (Entity) carries a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 107.9 million in FY2024 (+1.1%), 106.7 million in FY2023 (-0.4%), 107.1 million in FY2022 (-15.1%) and 126.2 million in FY2021 (+3.9%).
  • The Q2 2026 figure represents the lowest quarterly Shares Outstanding (Entity) since Q3 2015.
  • Year-over-year, Shares Outstanding (Entity) has declined for six consecutive quarters, with an average decline of 1.6% over the last eight quarters.
  • The fastest year-over-year change in Shares Outstanding (Entity) over five years came in Q2 2022 (growth of 4.7%), and the weakest in Q2 2023 (a decline of 16.6%).
  • Business Quant data shows REGN's Shares Outstanding (Entity) at 104 million (Q1 2026), 104.6 million (Q4 2025) and 103.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 941.36 Mn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 2.41 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 1.77 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 540.60 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 1.24 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 5.70 Bn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 102.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 102.80 Mn
Mar 31, 2026 104.00 Mn
Dec 31, 2025 104.60 Mn
Sep 30, 2025 103.60 Mn
Jun 30, 2025 105.10 Mn
Mar 31, 2025 106.70 Mn
Dec 31, 2024 107.90 Mn
Sep 30, 2024 108.10 Mn
Jun 30, 2024 108.10 Mn
Mar 31, 2024 107.80 Mn
Dec 31, 2023 106.70 Mn
Sep 30, 2023 106.30 Mn
Jun 30, 2023 107.00 Mn
Mar 31, 2023 107.10 Mn
Dec 31, 2022 107.10 Mn
Sep 30, 2022 106.90 Mn
Jun 30, 2022 128.30 Mn
Mar 31, 2022 127.60 Mn
Dec 31, 2021 126.20 Mn
Sep 30, 2021 124.60 Mn
API Access

Regeneron Pharmaceuticals Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=REGN&period=max&api_key=YOUR_API_KEY